These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 25605554)

  • 1. Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort.
    Dall'Era M; Cisternas MG; Smilek DE; Straub L; Houssiau FA; Cervera R; Rovin BH; Mackay M
    Arthritis Rheumatol; 2015 May; 67(5):1305-13. PubMed ID: 25605554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Good Long-Term Renal Outcomes in Lupus Nephritis: Results from a Single Lupus Cohort.
    Fung WA; Su J; Touma Z
    Biomed Res Int; 2017; 2017():5312960. PubMed ID: 28904963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is serum uric acid a predictor of long-term renal outcome in lupus nephritis?
    Ugolini-Lopes MR; Gavinier SS; Leon E; Viana VT; Borba EF; Bonfá E
    Clin Rheumatol; 2019 Oct; 38(10):2777-2783. PubMed ID: 31154554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial.
    Tamirou F; Lauwerys BR; Dall'Era M; Mackay M; Rovin B; Cervera R; Houssiau FA;
    Lupus Sci Med; 2015; 2(1):e000123. PubMed ID: 26629352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinuria and serum creatinine after 12 months of treatment for lupus nephritis as predictors of long-term renal outcome: a case-control study.
    Braga FNHF; das Chagas Medeiros MM; Junior ABV; de Sousa Lima ME; Barros LCM; Pontes MX; de Sousa Lima AW; Fernandes PFCBC
    Adv Rheumatol; 2022 Jan; 62(1):2. PubMed ID: 34983697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early proteinuria response: a valid real-life situation predictor of long-term lupus renal outcome in an ethnically diverse group with severe biopsy-proven nephritis?
    Ugolini-Lopes MR; Seguro LPC; Castro MXF; Daffre D; Lopes AC; Borba EF; Bonfá E
    Lupus Sci Med; 2017; 4(1):e000213. PubMed ID: 29238603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
    Abujam B; Cheekatla S; Aggarwal A
    Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes.
    Mackay M; Dall'Era M; Fishbein J; Kalunian K; Lesser M; Sanchez-Guerrero J; Levy DM; Silverman E; Petri M; Arriens C; Lewis EJ; Korbet SM; Conti F; Tesar V; Hruskova Z; Borba EF; Bonfa E; Chan TM; Rathi M; Gupta KL; Jha V; Hasni S; West MR; Solomons N; Houssiau FA; Romero-Diaz J; Mejia-Vilet J; Rovin BH
    Arthritis Rheumatol; 2019 Mar; 71(3):411-419. PubMed ID: 30225865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term data on tacrolimus treatment in lupus nephritis.
    Yap DY; Ma MK; Mok MM; Kwan LP; Chan GC; Chan TM
    Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission of proteinuria under therapeutic intervention and the renal outcomes in Japanese patients with lupus nephritis class III and IV.
    Okabayashi Y; Tsuboi N; Haruhara K; Kanzaki G; Koike K; Miyazaki Y; Kawamura T; Ogura M; Yokoo T
    Mod Rheumatol; 2020 Jan; 30(1):125-131. PubMed ID: 30557058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
    Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
    Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to treatment as a predictor of longterm outcome in patients with lupus nephritis.
    Fraenkel L; MacKenzie T; Joseph L; Kashgarian M; Hayslett JP; Esdaile JM
    J Rheumatol; 1994 Nov; 21(11):2052-7. PubMed ID: 7869309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum albumin at 1 year predicts long-term renal outcome in lupus nephritis.
    Domingues V; Levinson BA; Bornkamp N; Goldberg JD; Buyon J; Belmont HM
    Lupus Sci Med; 2018; 5(1):e000271. PubMed ID: 30233806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal biopsy in the management of lupus nephritis during pregnancy.
    Chen TK; Gelber AC; Witter FR; Petri M; Fine DM
    Lupus; 2015 Feb; 24(2):147-54. PubMed ID: 25249595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Outcome of Lupus Nephritis Class II in Argentine Patients: An Open Retrospective Analysis.
    Collado MV; Dorado E; Rausch S; Gomez G; Khoury M; Zazzetti F; Gargiulo M; Suarez L; Chaparro R; Paira S; Galvan L; Juarez V; Pisoni C; Garcia M; Martinez L; Alvarez A; Alvarez C; Barreira J; Sarano J
    J Clin Rheumatol; 2016 Sep; 22(6):299-306. PubMed ID: 27152693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of one year outcome in lupus nephritis: the importance of renal biopsy.
    Esdaile JM; Federgreen W; Quintal H; Suissa S; Hayslett JP; Kashgarian M
    Q J Med; 1991 Nov; 81(295):907-18. PubMed ID: 1808631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.
    Kiani AN; Johnson K; Chen C; Diehl E; Hu H; Vasudevan G; Singh S; Magder LS; Knechtle SJ; Petri M
    J Rheumatol; 2009 Oct; 36(10):2224-30. PubMed ID: 19648301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe lupus nephritis: the predictive value of a ≥ 50% reduction in proteinuria at 6 months.
    Korbet SM; Lewis EJ;
    Nephrol Dial Transplant; 2013 Sep; 28(9):2313-8. PubMed ID: 23787551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.